Abstract Ferroptosis is a critical driver of cardiomyocyte death during myocardial ischemia-reperfusion (I/R) injury. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is well-established as a key regulator of cholesterol metabolism; however, its role in modulating cardiomyocyte death, particularly ferroptosis, in the context of I/R injury remains poorly defined. Plasma PCSK9 level was determined by ELISA in patients with acute myocardial infarction 12 h after PCI.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Zelong
Contact Zelong, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack